A study for soya bean protein impacts of lipids metabolism of hyperlipemia and relative risk factors of heart diseases

A study for soya bean protein impacts of lipids metablism of hyperlipemia and relative risk factors of heart diseases

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-08000241

Enrollment

Unknown

Registered

2008-12-22

Start date

2008-12-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperlipemia

Interventions

Group 2:casein 25 g/day, 8 weeks

Group 1:soya bean protein powder 25g/day, 8 weeks

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. >18 years old, not smoker; 2. TC>5.7, LDL-c>3.61; 3. Volunteer.

Exclusion criteria

Exclusion criteria: 1. atherosclerosis disorders include angina, cerebrovascular ischemia; unnormal blood pressure and cardiac murmur; 2. any disorders in heart, lung, kidney, liver, blood or stomach, endocrine system; 3. fasting blood glucose > 6.99 mmol/L; 4. TC 5.65 mmol/L? 7. systolic pressure > 160 mm Hg or diastolic pressure > 100 mm Hg? 8. Reduce blood lipids drugs or blood vessel drugs were used during four weeks of the second follow-up; 9. Changing hormone therapy including oral anticoncipiens 10. Pregnancy or breed feeding woman; 11. Participate other clinical trial; 12. Abuse drugs or drinker; 13. Allergic reaction for study drug; 14. Cancers patients except skin squamous carcinoma.

Design outcomes

Primary

Measure	Time frame
Blood pressure;Total triglyceride;Fasting blood sugar;Total cholesterol;LDL-c;	—

Countries

China

Contacts

Public ContactZhuoqin Jiang

jiangzhq@mail.sysu.edu.cn+86 020 87330617

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026